Appears On
Episode Appearances
The a16z Show · Mar 9, 2026
Andrew Huberman: Peptides, Sleep Tech, and the End of Obesity
“Former Stanford researcher now at Neuralink working on brain-computer interfaces”
GLP-1 drugs and obesity treatmentPeptide therapy and gray market sourcingSleep technology and circadian biology
View Analysis